Fortrea
Cassandra Kennedy serves as the Chief Quality, Regulatory Affairs, & Sustainability Officer at Fortrea since May 2023. Previously, Cassandra held significant positions at Labcorp Drug Development from March 2018 to May 2023, including SVP, Global Head of Regulatory Compliance & Quality Assurance, and VP in the same field. Other roles include Principal at Compliance Insights, LLC, and SVP, Global Quality Assurance at Quintiles Transnational, spanning nearly two decades. Cassandra began their career as a Quality Assurance Auditor and Clinical Research Coordinator at Solvay Pharmaceuticals before advancing to US Quality Assurance Manager at Parexel. Educational qualifications include a BS in Clinical Psychology, Biology, and Chemistry from Lipscomb University and a Healthcare Compliance Certification from Seton Hall University.
This person is not in any teams
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.